Skip to main content
. 2024 Apr 29;12(6):e00073-24. doi: 10.1128/spectrum.00073-24

TABLE 5.

Performance of Ag-RDTs in diagnosing SARS-CoV-2 in symptomatic and asymptomatic participantsa

FlA LFIA
Symptomatic Asymptomatic Symptomatic Asymptomatic
Sensitivity 86.05 (72.07–94.70) 73.68 (56.90–86.60) 86.05 (72.07–94.70) 65.79 (48.64–80.37)
Specificity 83.33 (51.58–97.91) 97.71 (94.25–99.37) 91.67 (61.52–99.79) 97.71 (94.25–99.37)
LR+ 5.16 (1.45–18.40) 32.24 (12.01–86.51) 10.33 (1.58–67.69) 28.78 (10.64–77.89)
LR– 0.17 (0.08–0.37) 0.27 (0.16–0.46) 0.15 (0.07–0.33) 0.35 (0.23–0.54)
PPV 65.05 (34.31–86.90) 92.08 (81.24–96.89) 77.49 (34.43–95.76) 90.56 (78.00–96.29)
NPV 94.31 (88.32–97.32) 91.15 (85.81–94.61) 95.17 (90.20–97.69) 89.55 (84.64–93.02)
Accuracy 84.05 (71.68–92.53) 91.35 (86.73–94.76) 90.26 (79.22–96.60) 89.73 (84.85–93.46)
AUC 0.85 (71.68–92.53) 0.86 (0.80–0.90) 0.89 (0.78–0.96) 0.82 (0.76–0.87)
a

LR+/–: positive and negative likelihood ratio; PPV: positive predictive value; NPV: negative predictive value; AUC= area under the curve; FIA = SD Biosensor Standard F COVID-19 Ag Test; LFIA = Sure Status COVID-19 Antigen Card Test.